Healthcare & Life Sciences
Hemerion Therapeutics
Francewww.hemerion.com
Hemerion Therapeutics is a series a startup based in France. 3 investors tracked.
Activeseries-a
series-a
Stage
3
Investors
About Hemerion Therapeutics
Hemerion Therapeutics is a startup based in France. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Hemerion Therapeutics develops a unique drug-device combination therapy for glioblastoma, the most aggressive form of brain cancer. The technology integrates a photosensitizing drug with a photonic device to destroy tumor cells during surgery, improving survival and quality of life for patients.
Explore Hemerion Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.